Search
Lexeo Therapeutics Inc
LXEOAdd to Watchlist
4.930USD
-0.050-1.00%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
359.88MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Lexeo Therapeutics Inc is 9.20, ranking 8 out of 389 in the Biotechnology & Medical Research industry. The average price target is 18.50, with a high of 30.00 and a low of 12.00.
Analyst Rating
Based on
10
analysts
Strong Buy
Current Rating
20.900
Target Price
+323.94%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
560
Total
5
Median
6
Average
Company name
Ratings
Analysts
Lexeo Therapeutics Inc
LXEO
10
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
IQVIA Holdings Inc
IQV
26
argenx SE
ARGX
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Lexeo Therapeutics Inc's price target?
Analysts forecast that Lexeo Therapeutics Inc's price target is USD 18.50, with the highest forecast at USD 30.00 and the lowest forecast at USD 12.00.
How have Lexeo Therapeutics IncLXEO's recent earnings per share performed?
The market expectation was USD -0.25, while Lexeo Therapeutics IncLXEO's earnings per share (EPS) for the previous quarter was USD -0.27. EPS for the next quarter is expected at USD -0.28.
What is the analyst rating for Lexeo Therapeutics Inc?
Based on the ratings of Lexeo Therapeutics Inc's stock from 10 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.
